Correlation Engine 2.0
Clear Search sequence regions


  • acids (3)
  • Adiponectin (3)
  • BL (6)
  • blood (1)
  • breast cancer (4)
  • c57bl mice (1)
  • cell (6)
  • claudin (6)
  • Claudin 1 (2)
  • Cldn1 protein (1)
  • diet (10)
  • eicosanoids (3)
  • esters (4)
  • female (2)
  • growth (2)
  • growth control (1)
  • insulin (1)
  • leptin (3)
  • lovaza (2)
  • low (6)
  • mice (7)
  • MMTV Wnt- 1 (1)
  • obesity (7)
  • pilot projects (1)
  • Ptgs2 (1)
  • RelA (2)
  • risk factor (1)
  • serum (1)
  • Wnt 1 (5)
  • wnt1 protein (3)
  • women (3)
  • Sizes of these terms reflect their relevance to your search.

    Obesity induces chronic inflammation and is an established risk and progression factor for triple-negative breast cancers, including basal-like (BL) and claudin-low (CL) subtypes. We tested the effects of dietary supplementation with ethyl esters of the marine-derived anti-inflammatory omega-3 fatty acids eicosapentaenoic and docosahexaenoic acid (EPA+DHA; Lovaza) on growth of murine BL and CL mammary tumors. Female ovariectomized C57BL/6 mice were fed a control diet or a diet-induced obesity (DIO) diet with or without EPA+DHA (0.025%, resulting in blood levels of EPA and DHA comparable with women taking Lovaza 4 g/d) for 6 weeks. All mice were then orthotopically injected with Wnt-1 cells (a BL tumor cell suspension derived from MMTV-Wnt-1 transgenic mouse mammary tumors) or M-Wnt cells (a CL tumor cell line cloned from the Wnt-1 tumor cell suspension). Mice were killed when tumors were 1 cm in diameter. EPA+DHA supplementation did not significantly affect Wnt-1 or M-Wnt mammary tumor growth in normoweight control mice. However, EPA+DHA supplementation in DIO mice reduced growth of Wnt-1 and M-Wnt tumors; reduced leptin:adiponectin ratio and proinflammatory eicosanoids in the serum; improved insulin sensitivity; and decreased tumoral expression of COX-2 and phospho-p65. Thus, EPA+DHA supplementation in mouse models of postmenopausal BL and CL breast cancer offsets many of the protumorigenic effects of obesity. These preclinical findings, in combination with results from parallel biomarker studies in women, suggest that EPA+DHA supplementation may reduce the burden of BL and CL breast cancer in obese women. ©2015 American Association for Cancer Research.

    Citation

    Nikki A Ford, Emily L Rossi, Kelsey Barnett, Peiying Yang, Laura W Bowers, Brandon H Hidaka, Bruce F Kimler, Susan E Carlson, Imad Shureiqi, Linda A deGraffenried, Carol J Fabian, Stephen D Hursting. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer. Cancer prevention research (Philadelphia, Pa.). 2015 Sep;8(9):796-806

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 26100521

    View Full Text